Proliferative Vitreoretinopathy: A Review.
Idrees S, Sridhar J, Kuriyan AE.
Int Ophthalmol Clin. 2019 Winter;59(1):221-240. doi: 10.1097/IIO.0000000000000258.
Proliferative vitreoretinopathy.
Leaver PK.
Br J Ophthalmol. 1995 Oct;79(10):871-2. doi: 10.1136/bjo.79.10.871.
Proliferative vitreoretinopathy.
Claes C, Lafetá AP.
Dev Ophthalmol. 2014;54:188-95. doi: 10.1159/000360466. Epub 2014 Aug 26.
Proliferative Vitreoretinopathy Following Transscleral Diode Cyclophotocoagulation.
Bai A, Sharma A, Chiang MY.
J Glaucoma. 2023 Jun 1;32(6):e66-e68. doi: 10.1097/IJG.0000000000002222. Epub 2023 Mar 30.
Molecular Targets for Proliferative Vitreoretinopathy.
Wu F, Eliott D.
Semin Ophthalmol. 2021 May 19;36(4):218-223. doi: 10.1080/08820538.2021.1890791. Epub 2021 Feb 22.
[Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].
Schaub F, Abdullatif AM, Fauser S.
Ophthalmologe. 2021 Jan;118(1):3-9. doi: 10.1007/s00347-020-01173-8.
Proliferative vitreoretinopathy: an update on the current and emerging treatment options.
Ferro Desideri L, Artemiev D, Zandi S, Zinkernagel MS, Anguita R.
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):679-687. doi: 10.1007/s00417-023-06264-1. Epub 2023 Oct 16.
Proliferative vitreoretinopathy: a revised concept of retinal injury and response.
Assi A, Charteris D.
Br J Ophthalmol. 2024 Nov 22;108(12):1621-1626. doi: 10.1136/bjo-2023-324417.
[Proliferative Vitreoretinopathy: Therapeutic Strategies].
Schaub F, Enders P, Fauser S.
Klin Monbl Augenheilkd. 2016 Sep;233(9):1016-23. doi: 10.1055/s-0042-107947. Epub 2016 Aug 1.
Proliferative vitreoretinopathy: an overview.
Pastor JC.
Surv Ophthalmol. 1998 Jul-Aug;43(1):3-18. doi: 10.1016/s0039-6257(98)00023-x.
